145. ウエスト症候群 West syndrome Clinical trials / Disease details


臨床試験数 : 43 薬物数 : 54 - (DrugBank : 15) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 24

  
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2006-004286-33-CZ
(EUCTR)
11/05/200730/03/2007An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spasms.An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spasms. Infantile spasms
MedDRA version: 9.1;Level: LLT;Classification code 10021750;Term: Infantile spasms
Product Name: Ganaxolone
Product Code: SPT3162
Other descriptive name: Ganaxolone
Marinus Pharmceuticals, Inc.NULLNot RecruitingFemale: yes
Male: yes
54Czech Republic
2EUCTR2006-004285-13-CZ
(EUCTR)
11/05/200730/03/2007A double-blind, placebo-controlled, dose-ranging clinical study to evaluate the safety, tolerability, and antiepileptic activity of ganaxolone in treatment of patients with infantile spasms.A double-blind, placebo-controlled, dose-ranging clinical study to evaluate the safety, tolerability, and antiepileptic activity of ganaxolone in treatment of patients with infantile spasms. Infantile spasms
MedDRA version: 9.1;Level: LLT;Classification code 10021750;Term: Infantile spasms
Product Name: Ganaxolone
Other descriptive name: Ganaxolone
Marinus Pharmaceuticals, Inc.NULLNot RecruitingFemale: yes
Male: yes
54Czech Republic
3NCT00442104
(ClinicalTrials.gov)
January 200727/2/2007Open-label Extension to Protocol 1042-0500An Open-label Clinical Study to Evaluate the Safety and Antiepileptic Activity of Ganaxolone in Treatment of Patients Diagnosed With Infantile Spasms.Infantile SpasmsDrug: GanaxoloneMarinus PharmaceuticalsNULLTerminated4 Months24 MonthsAll54Phase 2United States
4NCT00441896
(ClinicalTrials.gov)
January 200727/2/2007A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile SpasmsA Double-blind, Placebo-controlled, Dose-ranging Clinical Study to Evaluate the Safety, Tolerability, and Antiepileptic Activity of Ganaxolone in Treatment of Patients With Infantile SpasmsInfantile SpasmsDrug: Ganaxolone;Other: PlaceboMarinus PharmaceuticalsNULLCompleted4 Months24 MonthsAll56Phase 2United States
5EUCTR2006-004286-33-PL
(EUCTR)
04/06/2007An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms.An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms. Infantile spasms
MedDRA version: 9.1;Level: LLT;Classification code 10021750;Term: Infantile spasms
Product Name: Ganaxolone
Product Code: SPT3162
Marinus Pharmceuticals, Inc.NULLNAFemale: yes
Male: yes
54Phase 2Czech Republic;Poland